Highlights

[PHARMA] QoQ Quarter Result on 2016-03-31 [#1]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 13-May-2016
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2016
Quarter 31-Mar-2016  [#1]
Profit Trend QoQ -     14.43%    YoY -     -42.19%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 582,816 515,215 531,796 559,195 680,150 524,413 512,845 8.86%
  QoQ % 13.12% -3.12% -4.90% -17.78% 29.70% 2.26% -
  Horiz. % 113.64% 100.46% 103.70% 109.04% 132.62% 102.26% 100.00%
PBT 4,069 19,923 21,487 26,538 23,717 25,337 25,056 -70.07%
  QoQ % -79.58% -7.28% -19.03% 11.89% -6.39% 1.12% -
  Horiz. % 16.24% 79.51% 85.76% 105.91% 94.66% 101.12% 100.00%
Tax -4,969 -7,275 -5,846 -8,068 -7,676 -5,362 -8,414 -29.50%
  QoQ % 31.70% -24.44% 27.54% -5.11% -43.16% 36.27% -
  Horiz. % 59.06% 86.46% 69.48% 95.89% 91.23% 63.73% 100.00%
NP -900 12,648 15,641 18,470 16,041 19,975 16,642 -
  QoQ % -107.12% -19.14% -15.32% 15.14% -19.69% 20.03% -
  Horiz. % -5.41% 76.00% 93.99% 110.98% 96.39% 120.03% 100.00%
NP to SH -836 13,061 14,995 18,379 16,062 19,971 16,217 -
  QoQ % -106.40% -12.90% -18.41% 14.43% -19.57% 23.15% -
  Horiz. % -5.16% 80.54% 92.46% 113.33% 99.04% 123.15% 100.00%
Tax Rate 122.12 % 36.52 % 27.21 % 30.40 % 32.36 % 21.16 % 33.58 % 135.56%
  QoQ % 234.39% 34.22% -10.49% -6.06% 52.93% -36.99% -
  Horiz. % 363.67% 108.76% 81.03% 90.53% 96.37% 63.01% 100.00%
Total Cost 583,716 502,567 516,155 540,725 664,109 504,438 496,203 11.38%
  QoQ % 16.15% -2.63% -4.54% -18.58% 31.65% 1.66% -
  Horiz. % 117.64% 101.28% 104.02% 108.97% 133.84% 101.66% 100.00%
Net Worth 531,169 531,250 524,177 515,906 529,786 534,373 528,477 0.34%
  QoQ % -0.02% 1.35% 1.60% -2.62% -0.86% 1.12% -
  Horiz. % 100.51% 100.52% 99.19% 97.62% 100.25% 101.12% 100.00%
Dividend
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Div 7,773 10,365 12,949 10,354 18,134 23,312 18,134 -43.00%
  QoQ % -25.01% -19.95% 25.06% -42.90% -22.21% 28.56% -
  Horiz. % 42.87% 57.16% 71.41% 57.10% 100.00% 128.56% 100.00%
Div Payout % - % 79.37 % 86.36 % 56.34 % 112.90 % 116.73 % 111.82 % -
  QoQ % 0.00% -8.09% 53.28% -50.10% -3.28% 4.39% -
  Horiz. % 0.00% 70.98% 77.23% 50.38% 100.97% 104.39% 100.00%
Equity
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Net Worth 531,169 531,250 524,177 515,906 529,786 534,373 528,477 0.34%
  QoQ % -0.02% 1.35% 1.60% -2.62% -0.86% 1.12% -
  Horiz. % 100.51% 100.52% 99.19% 97.62% 100.25% 101.12% 100.00%
NOSH 259,107 259,146 258,981 258,859 259,064 259,027 259,057 0.01%
  QoQ % -0.02% 0.06% 0.05% -0.08% 0.01% -0.01% -
  Horiz. % 100.02% 100.03% 99.97% 99.92% 100.00% 99.99% 100.00%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin -0.15 % 2.45 % 2.94 % 3.30 % 2.36 % 3.81 % 3.25 % -
  QoQ % -106.12% -16.67% -10.91% 39.83% -38.06% 17.23% -
  Horiz. % -4.62% 75.38% 90.46% 101.54% 72.62% 117.23% 100.00%
ROE -0.16 % 2.46 % 2.86 % 3.56 % 3.03 % 3.74 % 3.07 % -
  QoQ % -106.50% -13.99% -19.66% 17.49% -18.98% 21.82% -
  Horiz. % -5.21% 80.13% 93.16% 115.96% 98.70% 121.82% 100.00%
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 224.93 198.81 205.34 216.02 262.54 202.45 197.97 8.84%
  QoQ % 13.14% -3.18% -4.94% -17.72% 29.68% 2.26% -
  Horiz. % 113.62% 100.42% 103.72% 109.12% 132.62% 102.26% 100.00%
EPS -0.32 5.04 5.79 7.10 6.20 7.71 6.26 -
  QoQ % -106.35% -12.95% -18.45% 14.52% -19.58% 23.16% -
  Horiz. % -5.11% 80.51% 92.49% 113.42% 99.04% 123.16% 100.00%
DPS 3.00 4.00 5.00 4.00 7.00 9.00 7.00 -43.01%
  QoQ % -25.00% -20.00% 25.00% -42.86% -22.22% 28.57% -
  Horiz. % 42.86% 57.14% 71.43% 57.14% 100.00% 128.57% 100.00%
NAPS 2.0500 2.0500 2.0240 1.9930 2.0450 2.0630 2.0400 0.33%
  QoQ % 0.00% 1.28% 1.56% -2.54% -0.87% 1.13% -
  Horiz. % 100.49% 100.49% 99.22% 97.70% 100.25% 101.13% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
RPS 223.10 197.23 203.57 214.06 260.36 200.75 196.32 8.86%
  QoQ % 13.12% -3.11% -4.90% -17.78% 29.69% 2.26% -
  Horiz. % 113.64% 100.46% 103.69% 109.04% 132.62% 102.26% 100.00%
EPS -0.32 5.00 5.74 7.04 6.15 7.64 6.21 -
  QoQ % -106.40% -12.89% -18.47% 14.47% -19.50% 23.03% -
  Horiz. % -5.15% 80.52% 92.43% 113.37% 99.03% 123.03% 100.00%
DPS 2.98 3.97 4.96 3.96 6.94 8.92 6.94 -42.94%
  QoQ % -24.94% -19.96% 25.25% -42.94% -22.20% 28.53% -
  Horiz. % 42.94% 57.20% 71.47% 57.06% 100.00% 128.53% 100.00%
NAPS 2.0333 2.0336 2.0066 1.9749 2.0280 2.0456 2.0230 0.34%
  QoQ % -0.01% 1.35% 1.61% -2.62% -0.86% 1.12% -
  Horiz. % 100.51% 100.52% 99.19% 97.62% 100.25% 101.12% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 -
Price 5.3000 5.5800 5.5000 5.7600 6.3600 6.5000 7.1300 -
P/RPS 2.36 2.81 2.68 2.67 2.42 3.21 3.60 -24.44%
  QoQ % -16.01% 4.85% 0.37% 10.33% -24.61% -10.83% -
  Horiz. % 65.56% 78.06% 74.44% 74.17% 67.22% 89.17% 100.00%
P/EPS -1,642.66 110.71 94.99 81.13 102.58 84.31 113.90 -
  QoQ % -1,583.75% 16.55% 17.08% -20.91% 21.67% -25.98% -
  Horiz. % -1,442.19% 97.20% 83.40% 71.23% 90.06% 74.02% 100.00%
EY -0.06 0.90 1.05 1.23 0.97 1.19 0.88 -
  QoQ % -106.67% -14.29% -14.63% 26.80% -18.49% 35.23% -
  Horiz. % -6.82% 102.27% 119.32% 139.77% 110.23% 135.23% 100.00%
DY 0.57 0.72 0.91 0.69 1.10 1.38 0.98 -30.21%
  QoQ % -20.83% -20.88% 31.88% -37.27% -20.29% 40.82% -
  Horiz. % 58.16% 73.47% 92.86% 70.41% 112.24% 140.82% 100.00%
P/NAPS 2.59 2.72 2.72 2.89 3.11 3.15 3.50 -18.11%
  QoQ % -4.78% 0.00% -5.88% -7.07% -1.27% -10.00% -
  Horiz. % 74.00% 77.71% 77.71% 82.57% 88.86% 90.00% 100.00%
Price Multiplier on Announcement Date
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Date 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 26/11/15 17/08/15 -
Price 5.1200 5.7000 5.6200 5.6000 6.1900 6.5000 5.6500 -
P/RPS 2.28 2.87 2.74 2.59 2.36 3.21 2.85 -13.76%
  QoQ % -20.56% 4.74% 5.79% 9.75% -26.48% 12.63% -
  Horiz. % 80.00% 100.70% 96.14% 90.88% 82.81% 112.63% 100.00%
P/EPS -1,586.88 113.10 97.06 78.87 99.84 84.31 90.26 -
  QoQ % -1,503.08% 16.53% 23.06% -21.00% 18.42% -6.59% -
  Horiz. % -1,758.12% 125.30% 107.53% 87.38% 110.61% 93.41% 100.00%
EY -0.06 0.88 1.03 1.27 1.00 1.19 1.11 -
  QoQ % -106.82% -14.56% -18.90% 27.00% -15.97% 7.21% -
  Horiz. % -5.41% 79.28% 92.79% 114.41% 90.09% 107.21% 100.00%
DY 0.59 0.70 0.89 0.71 1.13 1.38 1.24 -38.92%
  QoQ % -15.71% -21.35% 25.35% -37.17% -18.12% 11.29% -
  Horiz. % 47.58% 56.45% 71.77% 57.26% 91.13% 111.29% 100.00%
P/NAPS 2.50 2.78 2.78 2.81 3.03 3.15 2.77 -6.58%
  QoQ % -10.07% 0.00% -1.07% -7.26% -3.81% 13.72% -
  Horiz. % 90.25% 100.36% 100.36% 101.44% 109.39% 113.72% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

396  550  558  646 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LAMBO 0.0350.00 
 LUSTER 0.2250.00 
 MAHSING 1.18-0.06 
 KTB 0.155+0.04 
 LUSTER-WA 0.125-0.005 
 XOX 0.12-0.005 
 AT 0.09-0.01 
 MLAB 0.0350.00 
 DNEX 0.235+0.045 
 DNEX-WD 0.05+0.015 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. LUSTER - IS IT ANOTHER GLOVE TITAN? HIDDEN WINNER(S) OF PHARMACEUTICAL DEMAND PENT UP
2. IT'S A TIME FOR THIS GLOVES GOING TO SKYROCKET!!! Follow Kim's Stockwatch!
3. Mah Sing: buyers be forewarned - Koon Yew Yin Koon Yew Yin's Blog
4. SUPERMAX - BEYOND GLOVES !!! freetospeak
5. LET'S GET ROLLING THIS GLOVES TO NEXT LEVEL!!! Follow Kim's Stockwatch!
6. PublicInvest Research Daily - 19 October 2020 PublicInvest Research
7. Covid 19 cases in Malaysia - Koon Yew Yin Koon Yew Yin's Blog
8. SUPERMAX OBM - The George Soros bet AGAIN? (REVISIT) freetospeak
PARTNERS & BROKERS